Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Tuberous Sclerosis 3Seizures 2Lennox Gastaut Syndrome 2Epilepsies, Myoclonic 2Prostatic Neoplasms 1Neoplasms 1Marijuana Abuse 1Liver Cirrhosis 1Glioblastoma 1Carcinoma, Intraductal, Noninfiltrating 1Cancer Pain 1Breast Carcinoma In Situ 1Behavior 1

Interventions

Specimen Handling 6Tamoxifen 4ruxolitinib 1pembrolizumab 1exemestane 1Watchful Waiting 1Surveys and Questionnaires 1Starch 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Radiation Dose Hypofractionation 1Radiation 1Protons 1Proton Therapy 1Omacor 1Observation 1Methods 1Metformin 1Magnetic Resonance Spectroscopy 1Letrozole 1Laser Therapy 1Interviews as Topic 1Hypnosis, Anesthetic 1Genotype 1Educational Status 1Early Intervention, Educational 1Decision Support Techniques 1Counseling 1Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Carcinoma In Situ × Cannabidiol × 90 days × Clear all
NCT06538389 2026-04-30

High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer

City of Hope Medical Center

Phase 2 Recruiting
36 enrolled
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡